Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism

Parkinsonism and Related Disorders

Volumn 13, Issue SUPPL. 3, 2007, Pages

  Deutch, Ariel Y ^a,b   Colbran, Roger J ^b   Winder, Danny J ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CaMKII; Dendritic remodeling; F actin; Medium spiny neurons; Parkinson's disease; Synaptic plasticity

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CINNARIZINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; F ACTIN; FLUNARIZINE; GLUTAMIC ACID; HALOPERIDOL; LEVODOPA; NIMODIPINE; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN);

ARTICLE; DENDRITIC CELL; DENERVATION; DNA FLANKING REGION; EXCITOTOXICITY; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NERVE FIBER; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRIATE CORTEX;

ANIMALS; CORPUS STRIATUM; DENDRITES; DISEASE MODELS, ANIMAL; NEURONAL PLASTICITY; NEURONS; PARKINSONIAN DISORDERS;

EID: 38949177433     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(08)70012-9     Document Type: Article

References (46)

1. Wickens J., and Arbuthnott G. Structural and functional interactions in the striatum at the receptor level. In: Dunnett S., Bentivoglio M., Bjorklund A., and Hokfelt T. (Eds). Dopamine, vol. 21 of Handbook of Chemical Neuroanatomy (2005), Elsevier, Amsterdam 199-236
2. Cepeda C., Hurst R., Altemus K., Flores-Hernandez J., Calvert C., Jokel E., et al. Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol 85 (1998) 659-670
3. Day M., Wang Z., Ding J., An X., Ingham C., Shering A., et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9 (2006) 251-259
4. Crick F. Do spines twitch?. Trends Neurosci 5 (1984) 44-46
5. DeFelipe J. Brain plasticity and mental processes: Cajal again. Nat Rev Neurosci 7 (2006) 811-817
6. Zaja-Milatovic S., Milatovic D., Schantz A., Zhang J., Montine K., Samii A., et al. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurol 64 (2005) 545-547
7. Stephens B., Mueller A., Shering A., Hood S., Taggart P., Arbuthnott G., et al. Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 132 (2005) 741-754
8. Ingham C., Hood S., and Arbuthnott G. Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res 503 (1989) 334-338
9. Segal M., and Andersen P. Dendritic spines shaped by synaptic activity. Curr Opin Neurobiol 10 (2000) 582-586
10. Rodriguez J., and Pickel V. Enhancement of N-methyl-D-aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudateputamen nucleus after chronic haloperidol administration. Synapse 33 (1999) 289-303
11. Bamford N., Robinson S., Palmiter R., Joyce J., Moore C., and Meshul C. Dopamine modulates release from corticostriatal terminals. J Neurosci 43 (2004) 9541-9552
12. Neely MD, Schmidt DE, Deutch AY. Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neurosci, In Press, doi: 10.1016/j.neuroscience.2007.06.044.
13. Segal M. Dendritic spines for neuroprotection: a hypothesis Trends Neurosci 1005; 18:468-471
14. 2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. Neurosci 20 (2000) 8987-8995
15. Ton T., Heckbert S., Longstreth Jr. W., Rossing M., Kukull W., Franklin G., et al. Calcium channel blockers and beta-blockers in relation to Parkinson's disease. Parkinsonism Relat Disord 13 (2007) 165-169
16. Xia Z., and Storm D. The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci 6 (2005) 267-276
17. 2+ oscillations. Science 279 (1998) 227-230
18. 2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J Neurochem 68 (1997) 2119-2128
19. Colbran R. Targeting of calcium/calmodulin-dependent protein kinase II. Biochem J 378 (2004) 1-16
20. Robison A., Bartlett R., Bass M., and Colbran R. Differential modulation of Ca2+/calmodulin-dependent protein kinase II activity by regulated interactions with N-methyl-D-aspartate receptor NR2B subunits and alpha-actinin. J Biol Chem 280 (2005) 39316-39323
21. Tsui J., Inagaki M., and Schulman H. Calcium/calmodulin-dependent protein kinase II (CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation. J Biol Chem 280 (2005) 9210-9216
22. Svenningsson P., Nishi A., Fisone G., Girault J., Nairn A., and Greengard P. DARPP-32: An integrator of neurotransmission. Ann Rev Pharmacol Toxicol 44 (2004) 269-296
23. Halpain S., Hipolito A., and Saffer L. Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci 18 (1998) 9835-9844
24. Wu G., and Cline H. Stabilization of dendritic arbor structure in vivo by CaMKII. Science 279 (1998) 222-226
25. Gaudilliere B., Konishi Y., de la Iglesia N., Yao G., and Bonni A. A CaMKIINeuroD signaling pathway specifies dendritic morphogenesis. Neuron 41 (2004) 229-241
26. Robison A., Bass M., Jiao Y., MacMillan L., Carmody L., Bartlett R., et al. Multivalent interactions of calcium/calmodulin- dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2. J Biol Chem 280 (2005) 35329-35336
27. Brown A., Deutch A., and Colbran R. Dopamine depletion alters phosphorylation of striatal proteins in a model of parkinsonism. Eur J Neurosci 22 (2005) 247-256
28. 2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental Parkinsonism. J Neurosci 24 (2004) 5283-5291
29. Oh J., Vaughan C., and Chase T. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Brain Res 821 (1999) 433-442
30. Whitlock J., Heynen A., Shuler M., and Bear M. Learning induces long-term potentiation in the hippocampus. Science 313 (2006) 1093-1097
31. Yin H., and Knowlton B. The role of the basal ganglia in habit formation. Nat Rev Neurosci 7 (2006) 464-476
32. Centonze D., Picconi B., Gubellini P., Bernardi G., and Calabresi P. Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci 13 (2001) 1071-1077
33. Tang K., Low M., Grandy D., and Lovinger D. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci USA 98 (2001) 1255-1260
34. Lovinger D., Tyler E., and Merritt A. Short- and long-term synaptic depression in rat neostriatum. J Neurophysiol 70 (1993) 1937-1949
35. Wang Z., Kai L., Day M., Ronesi J., Yin H., Ding J., et al. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50 (2006) 443-452
36. Gerdeman G., Ronesi J., and Lovinger D. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5 (2002) 446-451
37. Mulkey R., Endo S., Shenolikar S., and Malenka R. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long- term depression. Nature 369 (1994) 486-488
38. Hansel C., de Jeu M., Belmeguenai A., Houtman S., Buitendijk G., Andreev D., et al. alphaCaMKII is essential for cerebellar LTD and motor learning. Neuron 51 (2006) 835-843
39. Partridge J., Tang K., and Lovinger D. Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol 84 (2000) 1422-1429
40. Charpier S., and Deniau J. In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation. Proc Natl Acad Sci USA 94 (1997) 7036-7040
41. Norman E., Egli R., Colbran R., and Winder D. A potassium channel blocker induces a long-lasting enhancement of corticostriatal responses. Neuropharmacology 48 (2006) 311-321
42. Picconi B., Centonze D., Hakansson K., Bernardi G., Greengard P., Fisone G., et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 6 (2003) 501-506
43. Winder D., and Sweatt J. Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat Rev Neurosci 2 (2001) 461-474
44. Gong S., Zheng C., Doughty M., Losos K., Didkovsky N., Schambra U., et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425 (2003) 917-925
45. Heintz N. Gene expression nervous system atlas (GENSAT). Nat Neurosci 7 (2004) 483
46. Kreitzer A., and Malenka R. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 445 (2007) 643-647